| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |